LinkBIO Co., Ltd., is a start-up venture company providing support for biological drug discovery. It was established in May 2020 on the basis of technologies generated by The University of Tokyo.
Company overview
| Company name | LinkBIO Co., Ltd. |
|---|---|
| Location | The ICI Center, 5270 Terada, Toride-shi, Ibaraki Prefecture |
| Representative | Yuki Inami |
| Establishment date | May 2020 |
| Capital | ¥25 million, including capital reserve |
| Tasks | Support for drug discovery, and development of diagnostic agents, regenerative medicine reagents, etc. |
Officers
| President | Yuki Inami |
|---|---|
| Managing Director | Keitaro Yoshimoto (also Chief Technology Officer) |
Consultants
| Technology Advisor (Pharmacological Chemistry) | Dr. Masanobu Nagano (Project Assistant Professor, The University of Tokyo) |
|---|---|
| Technology Advisor (Analytical and Nucleic Acid Chemistry) | Dr. Koji Wakui (Researcher, DAIICHI SANKYO COMPANY, LIMITED) |
| Intellectual Property Advisor | Tsubasa Yamamoto (Lawyer and Patent Attorney) |
Investor
Collaboration partners
Subsidies
Receipt of support by the below financing programs at the time of the company’s start-up activities. We are very grateful.